Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride Ion SCHEMBL1502794 | 0.97 | ACHE (0.48) | ACHELMNAALOX12TSHRBCHE | |
| Water SCHEMBL2150213 | 0.97 | ACHE (0.48) | ACHELMNAALOX12TSHRBCHE | |
| Iodide SCHEMBL1502849 | 0.97 | ACHE (0.48) | ACHELMNAALOX12TSHRBCHE | |
| Bromide SCHEMBL1502843 | 0.97 | ACHE (0.48) | ACHELMNAALOX12TSHRBCHE | |
| Hydrochloric Acid SCHEMBL1502730 | 0.97 | ACHE (0.48) | ACHELMNAALOX12TSHRBCHE | |
| SCHEMBL2150406 | 0.91 | ACHE (0.42) | ACHELMNAALOX12TSHRBCHE | |
| Perchlorate SCHEMBL2150382 | 0.87 | RAB9A (0.41) | ACHELMNAALOX12TSHRBCHE | |
| SCHEMBL23058911 | 0.81 | SLC22A2 (0.48) | ACHELMNAALOX12TSHRBCHE | |
| SCHEMBL840717 | 0.79 | ACHE (0.43) | ACHELMNAALOX12TSHRBCHE | |
| SCHEMBL1108049 | 0.78 | SLC22A2 (0.48) | ACHELMNABCHEHTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250162986-A1 | Compounds and compositions for neurodegenerative diseases | UNIVERSIDADE NOV A DE LISBOA (PT) | 2025-05-22 | — | — | US | disclosed |
| EP-4482483-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2025-01-01 | — | — | EP | disclosed |
| WO-2023156983-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-24 | — | — | WO | disclosed |
| EP-4230201-A1 | COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-23 | — | — | EP | disclosed |
| US-9057929-B2 | Quinolinium single crystals for use in nonlinear optics | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-06-16 | — | — | US | disclosed |
| US-20140204457-A1 | QUINOLINIUM SINGLE CRYSTALS FOR USE IN NONLINEAR OPTICS | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2014-07-24 | — | — | US | disclosed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250162986-A1 | Compounds and compositions for neurodegenerative diseases | CLN6, HTT, SNCA | ACHE 40/4885LMNA 1651/4885ALOX12 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.